2/23/2005

ID Biomedical may not be able to sell its flu vaccine to the U.S. in time for the current season or for the 2005-2006 season, but CEO Tony Holler said he is optimistic the firm will get approval to supply Fluviral for the 2006-2007 flu season. The FDA still needs to inspect the company's facilities and approve its proposals for clinical trials for its vaccine.

Full Story:
Reuters

Related Summaries